Feasibility and Preliminary Efficacy of a “Sit Less” Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes

Feasibility and Preliminary Efficacy of a “Sit Less” Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes

Authors of this article:

Chorong Park^{1, 2, 3} ;   Mary S Dietrich^{4, 5} ;   Britta Larsen⁶ ;   Lindsay S Mayberry⁷ ;   Abigail Doyle^{4, 8} ;   Soojung Ahn⁹ ;   Jason Jean⁴ ;   Kevin Maquiling¹⁰ ;   Mulubrhan F Mogos⁴ ;   James M Muchira⁴ ;   Shelagh Mulvaney^{4, 11, 12}